| Darla Speigner, NP | |
|
100 St Marys Epworth Xing Ste B100, Newburgh, IN 47630-9161 | |
| (812) 853-9651 | |
| (812) 853-9899 |
| Full Name | Darla Speigner |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 100 St Marys Epworth Xing Ste B100, Newburgh, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154514941 | NPI | - | NPPES |
| P01427661 | Other | IA | RR MEDICARE |
| 1154514941 | Medicaid | IA | |
| 000884309B | Medicaid | GA |
| Entity Name | Northern Alabama Physicians, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669618310 PECOS PAC ID: 0143379388 Enrollment ID: O20090519000375 |
News Archive
Blueprint Medicines today announced that the U.S. Food and Drug Administration accepted the Company's Investigational New Drug (IND) applications to begin Phase 1 clinical trials for its two lead drug candidates: BLU-554 for the treatment of advanced hepatocellular carcinoma (HCC) and cholangiocarcinoma, and BLU-285 for unresectable, treatment-resistant gastrointestinal stromal tumor (GIST).
The brain's neurons are coupled together into vast and complex networks called circuits. Yet despite their complexity, these circuits are capable of displaying striking examples of collective behavior such as the phenomenon known as "neuronal avalanches," brief bursts of activity in a group of interconnected neurons that set off a cascade of increasing excitation.
Patrys Limited, a clinical stage biotechnology company is pleased to advise that it has been granted a second US patent for lead anti-cancer product PAT-LM1.
OptiNose Inc. announced the results from an analysis comparing the Phase II clinical trial obtained with its novel delivery technology to that of other formulations. The analysis suggests rapid absorption rate alone may not explain the efficacy in migraines treated with sumatriptan delivered with the Company's novel bi-directional technology. The results will be presented at the 2nd European Headache and Migraine Trust International on 28th of October 2010.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Darla Speigner, NP Po Box 3444, Evansville, IN 47733-3444 Ph: (812) 471-1591 | Darla Speigner, NP 100 St Marys Epworth Xing Ste B100, Newburgh, IN 47630-9161 Ph: (812) 853-9651 |
News Archive
Blueprint Medicines today announced that the U.S. Food and Drug Administration accepted the Company's Investigational New Drug (IND) applications to begin Phase 1 clinical trials for its two lead drug candidates: BLU-554 for the treatment of advanced hepatocellular carcinoma (HCC) and cholangiocarcinoma, and BLU-285 for unresectable, treatment-resistant gastrointestinal stromal tumor (GIST).
The brain's neurons are coupled together into vast and complex networks called circuits. Yet despite their complexity, these circuits are capable of displaying striking examples of collective behavior such as the phenomenon known as "neuronal avalanches," brief bursts of activity in a group of interconnected neurons that set off a cascade of increasing excitation.
Patrys Limited, a clinical stage biotechnology company is pleased to advise that it has been granted a second US patent for lead anti-cancer product PAT-LM1.
OptiNose Inc. announced the results from an analysis comparing the Phase II clinical trial obtained with its novel delivery technology to that of other formulations. The analysis suggests rapid absorption rate alone may not explain the efficacy in migraines treated with sumatriptan delivered with the Company's novel bi-directional technology. The results will be presented at the 2nd European Headache and Migraine Trust International on 28th of October 2010.
› Verified 3 days ago
Allison Jo Martin, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4055 Gateway Blvd, Newburgh, IN 47630 Phone: 812-858-3051 Fax: 812-858-3060 | |
Emily Christine York, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4055 Gateway Blvd, Newburgh, IN 47630 Phone: 812-858-3051 Fax: 812-858-3060 | |
Margie Huff, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4209 Gateway Blvd, Newburgh, IN 47630 Phone: 812-842-2800 Fax: 812-842-2901 | |
Kelli Shea Dempsey, ACNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4055 Gateway Blvd, Newburgh, IN 47630 Phone: 812-842-2210 Fax: 812-842-4599 | |
Jessica Solomon Ranes, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4199 Gateway Blvd Ste 3100, Newburgh, IN 47630 Phone: 812-842-4550 Fax: 812-842-4549 | |
Sydney Moats Schweikhard, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4209 Gateway Blvd, Newburgh, IN 47630 Phone: 812-842-2800 Fax: 812-842-2901 | |
Leslie S Hubert, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 St Marys Epworth Xing Ste B100, Newburgh, IN 47630 Phone: 812-853-9651 |